Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Wegen Wartungsarbeiten steht das KOBV-Portal am 11.03.2025 ggf. nur eingeschränkt zur Verfügung. Wir bitten um Ihr Verständnis.
Export
  • 1
    In: Infection and Immunity, American Society for Microbiology, Vol. 67, No. 1 ( 1999-01), p. 342-349
    Abstract: Merozoite surface protein 1 is a candidate for blood-stage vaccines against malaria parasites. We report here an immunization study of Saimiri monkeys with a yeast-expressed recombinant protein containing the C terminus of Plasmodium vivax merozoite surface protein 1 and two T-helper epitopes of tetanus toxin (yP 2 P 30 Pv200 19 ), formulated in aluminum hydroxide (alum) and block copolymer P1005. Monkeys immunized three times with yP 2 P 30 Pv200 19 in block copolymer P1005 had significantly higher prechallenge titers of immunoglobulin G (IgG) antibodies against the immunogen and asexual blood-stage parasites than those immunized with yP 2 P 30 Pv200 19 in alum, antigen alone, or phosphate-buffered saline (PBS) ( P 〈 0.05). Their peripheral blood mononuclear cell proliferative responses to immunogen stimulation 4 weeks after the second immunization were also significantly higher than those from the PBS control group ( P 〈 0.05). Upon challenge with 100,000 asexual blood-stage parasites 5 weeks after the last immunization, monkeys immunized with yP 2 P 30 Pv200 19 in block copolymer P1005 had prepatent periods longer than those for the control alone group ( P 〉 0.05). Three of the five animals in this group also had low parasitemia (peak parasitemia, ≤20 parasites/μl of blood). Partially protected monkeys had significantly higher levels of prechallenge antibodies against the immunogen than those unprotected ( P 〈 0.05). There was also a positive correlation between the prepatent period and titers of IgG antibodies against the immunogen and asexual blood-stage parasites and a negative correlation between accumulated parasitemia and titers of IgG antibodies against the immunogen ( P 〈 0.05). These results indicate that when combined with block copolymer and potent T-helper epitopes, the yeast-expressed P 2 P 30 Pv200 19 recombinant protein may offer some protection against malaria.
    Type of Medium: Online Resource
    ISSN: 0019-9567 , 1098-5522
    RVK:
    Language: English
    Publisher: American Society for Microbiology
    Publication Date: 1999
    detail.hit.zdb_id: 1483247-1
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages